139 related articles for article (PubMed ID: 87106)
1. Determination of cell mediated immunity against tumour associated antigens in patients of ENT.
Nowak R; Günther M; Jenssen HL; Seyfarth M; Werner H; Putzke HP
Acta Otolaryngol; 1979; 87(3-4):400-3. PubMed ID: 87106
[TBL] [Abstract][Full Text] [Related]
2. Cell-mediated immune reactions as probes of sensitization to tumour-associated antigens of methylcholanthrene-induced mouse sarcomas.
Bubeník J; Indrová M; Malkovský M; Símová J
Arch Geschwulstforsch; 1981; 51(4):349-53. PubMed ID: 6172086
[TBL] [Abstract][Full Text] [Related]
3. [About the immunologic evidence of tumors in the E.N.T. field (author's transl)].
Kessler L; Knothe J; Irmscher H
Laryngol Rhinol Otol (Stuttg); 1981 Aug; 60(8):402-4. PubMed ID: 6180270
[TBL] [Abstract][Full Text] [Related]
4. Immunological tumour profile: organ-specific carcinoma diagnosis in patients employing the macrophage electrophoretic mobility test.
Müller M; Irmscher J; Fischer R; Heidl G; Grossmann H
Cancer Lett; 1977 Jan; 2(3):139-45. PubMed ID: 65215
[TBL] [Abstract][Full Text] [Related]
5. Tumour specificity of the SCM test for cancer diagnosis.
Chaitchik S; Asher O; Deutsch M; Weinreb A
Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1165-70. PubMed ID: 2416568
[TBL] [Abstract][Full Text] [Related]
6. Evaluation and development of the macrophage electrophoretic mobility (MEM) test for malignant disease.
Pritchard JA; Moore JL; Sutherland WH; Joslin CA
Br J Cancer; 1973 Jan; 27(1):1-9. PubMed ID: 4686176
[TBL] [Abstract][Full Text] [Related]
7. Failure to obtain positive MEM tests in either cell-mediated immune conditions in the guinea-pig or in human cancer.
Arvilommi H; Dale MM; Desai HN; Mongar JL; Richardson M
Br J Cancer; 1977 Nov; 36(5):545-9. PubMed ID: 588418
[TBL] [Abstract][Full Text] [Related]
8. [Lymphocyte reactivity against fetal antigens during the growth and regression of experimental tumors].
Schlott B; Gryschek G; Albrecht S; Pasternak G
Biomed Biochim Acta; 1985; 44(5):805-11. PubMed ID: 4062925
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte sensitization detected in lymphomatous hamadryas baboons by the macrophage electrophoretic mobility assay.
Malkovský M; Bubeník J; Indzhiya LV; Lapin BA; Yakovleva LA
Folia Biol (Praha); 1980; 26(1):70-3. PubMed ID: 6244991
[TBL] [Abstract][Full Text] [Related]
10. Cancer diagnostic test of Field and Caspary: Part I. Spontaneous aggregation of lymphocytes in saline suspension is blocked by albumin and histone in normals but not in various disease states: the lymphocyte aggregation blocking test.
Bjerrum OW; Kast RE
Med Hypotheses; 1980 Jan; 6(1):59-62. PubMed ID: 6991895
[TBL] [Abstract][Full Text] [Related]
11. Cell-mediated immune reactions to human tumors.
Perlmann P; Troye M; Pape GR
Cancer; 1977 Jul; 40(1 Suppl):448-57. PubMed ID: 69485
[No Abstract] [Full Text] [Related]
12. In vitro-demonstration of cellular hypersensitivity to tumour antigens in man.
Andersen V; Kjaer M; Bendixen G
Ser Haematol; 1972; 5(5):3-21. PubMed ID: 4598039
[No Abstract] [Full Text] [Related]
13. Lymphocyte-mediated immune responses in neoplasia.
Pilch YH; Golub SH
Am J Clin Pathol; 1974 Aug; 62(2):184-211. PubMed ID: 4602086
[No Abstract] [Full Text] [Related]
14. Immunologic approaches to the diagnosis of cancer.
Herberman RB
Cancer; 1976 Jan; 37(1 suppl):549-61. PubMed ID: 55303
[TBL] [Abstract][Full Text] [Related]
15. Specific lymphocyte sensitization in cancer: is there a common antigen in human malignant neoplasia?
Caspary EA; Field EJ
Br Med J; 1971 Jun; 2(5762):613-7. PubMed ID: 4103278
[TBL] [Abstract][Full Text] [Related]
16. [Cytopherometry in neurologic diseases (author's transl)].
Meyer-Rienecker HJ; Jenssen HL; Köhler H; Werner H
Fortschr Neurol Psychiatr Grenzgeb; 1977 Nov; 45(11):615-29. PubMed ID: 336499
[TBL] [Abstract][Full Text] [Related]
17. The need to establish whether the leukocyte adherence inhibition test is a reliable assay of tumor immunity in humans.
Hellström KE; Hellström I
Cancer Res; 1979 Feb; 39(2 Pt 2):649-50. PubMed ID: 83919
[TBL] [Abstract][Full Text] [Related]
18. Specificities in human cell-mediated cytotoxicity.
Takasugi M; Akira D; Takasugi J; Mickey MR
J Natl Cancer Inst; 1977 Jul; 59(1):69-75. PubMed ID: 69035
[TBL] [Abstract][Full Text] [Related]
19. Immunologic defenses against cancer.
Bernstein ID
J Pediatr; 1973 Dec; 83(6):906-18. PubMed ID: 4585830
[No Abstract] [Full Text] [Related]
20. An introduction to tumour immunology.
Keith J
Mater Med Pol; 1984; 16(1):54-64. PubMed ID: 6394909
[No Abstract] [Full Text] [Related]
[Next] [New Search]
